AI support for heart team treatment decisions
Part of Heart & circulation clinical trials.
This study tests whether an AI tool called Revaz AI helps heart teams make better treatment decisions for people with blocked coronary arteries. It looks at how the AI affects the team's discussions and choices, which could lead to more personalized care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been referred to a heart team at a participating center to discuss treatment for coronary artery disease.
- You have at least one blocked artery confirmed by an angiogram: a 50% or more blockage in the left main artery, or a 70% or more blockage in any other coronary artery.
- You have not already been enrolled in this trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two ways of deciding on heart treatment for people with diabetes and blockages in all three main heart arteries. You'll be assigned by chance to either have a team of heart specialists discuss your case in real time (using an electronic system) or receive the usual way of making the decision, to see if one leads to better outcomes.
This trial tests an artificial-intelligence tool that uses a heart ultrasound to help guide stent treatment. It may help doctors choose the best way to treat blockages and improve stent results for people with symptoms from reduced blood flow to the heart.
This trial uses artificial intelligence to analyze heart ultrasound images and detect blocked arteries in people with suspected coronary artery disease. It aims to see if AI can accurately find problems without needing more invasive tests.
This trial uses an artificial intelligence (AI) tool to analyze heart CT scans (CCTA) and identify dangerous plaque buildup that could lead to a heart attack. It aims to see if AI can better predict high-risk plaques in people with known or suspected coronary artery disease (CAD).
This study is testing a new tool to help patients and doctors decide together on the best procedure (like stents or bypass surgery) for blocked heart arteries. It aims to make the decision process clearer and more personalized.
This study tests whether a new AI tool can help primary care doctors better manage chronic conditions in their community practice. You might join if you're a doctor with at least 3 years of experience working at a local health center.
Hear when a new Coronary artery disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.